DANAHER, THERMO FISHER SCIENTIFIC, INC. and HOLOGIC, INC. were Dominating the Global Molecular Point of Care Testing (using NAAT) Market in 2021

The Global Molecular Point of Care Testing (Using NAAT) Market is expected to grow with a CAGR of 10.8% in the forecast period of 2021 to 2028. The years considered for the study are as mentioned below.

Access Full Report @ https://www.databridgemarketresearch.com/reports/global-molecular-point-of-care-testing-using-naat-market

The global molecular point of care testing (using NAAT) market is a highly consolidated market, which includes a specific number of key players. The market has witnessed increased strategic developments owing to favorable market scenarios.

The major players dealing in the Global molecular point of care testing (using NAAT) market are introducing a strong range of products provider along with launching new products and adopting strategic initiatives such as acquisition, agreement, business expansion, award, and recognition into the market. This helped companies to maximize sales with an enhanced product portfolio.

For instance:

  • In April 2020, Danaher made an announcement for the completion of the sale of its label-free biomolecular characterization, microcarriers, and particle validation standards. The company sold these ventures in order to obtain regulatory approval for its acquisition of the GE Biopharma business. This will help the company in the launching of further new services

Danaher is the dominating player in the global molecular point of care testing (using NAAT)  market. Some of the other key players existing in the market are Thermo Fisher Scientific Inc., Hologic, Inc., BD, F. Hoffmann-La Roche Ltd, ABBOTT, Seegene Inc., bioMérieux SA, QIAGEN, Bio-Rad Laboratories, Inc., PerkinElmer Inc., Grifols, S.A., Quidel Corporation, GenMark Diagnostics, Inc., SD Biosensor, INC., Oxford Nanopore Technologies, Wondfo, Randox Laboratories Ltd., Meridian Bioscience, Sekisui Diagnostics, QuantuMDx Group Ltd., Lucira Health Inc., binx health, inc., Sysmex (A Subsidiary of Sysmex Corporation), Co-Diagnostics, Inc., among others.

Molecular Point Of Care Testing (Using NAAT) MarketDANAHER

Danaher was founded in the year 1969, and it is headquartered in Washington D.C., U.S. The company focuses on developing and manufacturing medical devices products and improving customer satisfaction. The company operates its business via several business segments such as life sciences, diagnostics, and environmental & applied solutions, where diagnostics are the market-focused segment.

The company provides products via various product categories such as life sciences, diagnostics, and environmental & applied solutions, where diagnostics is the market-focused category.

For instance,

  • In March 2020, Danaher completed the acquisition of the Biopharma business from General Electric. In the future, these businesses will be called Cytiva and known as a standalone operating company within Danaher's Life Sciences segment. Thus, this acquisition has helped the company in diversifying its segment portfolio

The company has a wide presence across the Americas, Europe, Asia-Pacific, and the Middle East and Africa. The company also has various subsidiary companies Cepehid Inc (U.S.), Beckman Coulter (U.S.), Pall Corporation (U.S.), Hach Company (U.S.), among others.

THERMO FISHER SCIENTIFIC INC

Thermo Fisher Scientific Inc., founded in the year 1960, is headquartered in Massachusetts, U.S.  The company focuses on manufacturing scientific instruments, consumables, and chemicals. The company offers analytical instruments, laboratory equipment, software, services, consumables, reagents, chemicals, and others. The company operates its business via several business segments, including life science solutions, analytical instruments, specialty diagnostics, and laboratory products & services, where specialty diagnostics is the market-focused segment.

The company provides products via various product categories such as clinical & diagnostics, life sciences, industrial & applied science, and lab solutions, where clinical & diagnostics and life sciences are the market-focused categories.

For instance,

  • In October 2021,  Thermo Fisher Scientific Corporation received FDA approval of TaqMan COVId-19 test SARS-COV molecular Assay. This will increase the product portfolio of the company and will contribute to the company revenue in the forecast period

The company has a presence across North America, Europe, the Middle East and Africa, Asia-Pacific. The company also has various subsidiaries, including Patheon (U.S.), Dionex (U.S.), Cole Palmer (U.S.), Affymertrix (U.S.), Phadea GmBH (Germany), among others

HOLOGIC INC.

Hologic Inc., founded in the year 1960, is headquartered in Massachusetts, U.S. The company focuses on manufacturing scientific instruments, consumables, and chemicals. The company offers analytical instruments, laboratory equipment, software, services, consumables, reagents, chemicals, and others. The company operates its business via several business segments, including diagnostic segment, breast health, GYN surgical, and skeleton health, where diagnostics is the market-focused segment.

The company provides products via various product categories such as tests, cytology, molecular diagnostics, collection devices, and screening technologies, in which molecular diagnostics is the market-focused category.

For instance,

  • In July 2021, Hologic, Inc. announced the CE Mark for the use of saliva samples with the Aptima SARS-CoV-2 assay in Europe. The Aptima SARS-CoV-2 test is a molecular diagnostic assay that detects the genetic material of the pathogen causing COVID-19. This will increase the demand for this instrument in the European region and will increase the revenue

The company has a presence across Asia-Pacific, Middle East & Africa, Latin America, and Europe. The company has various subsidiaries, including Hologic India LLP (India), Hologic International Holdings B.V.(Netherlands), Hologic ltd. (U.K.) Hologiv Suisse SA (Switzerland), Hologic Medicor GmbH( Germany), among others.